Overview

Ankylosing Spondylitis Market Dynamics:

The emergence of advanced products like biosimilars is the key factor responsible for the ankylosing spondylitis market growth. Furthermore, the growing prevalence of spondylitis owing to increased usage of smart phones, laptops and other electronic devices that enforce a strain on the spinal cord, lack of exercise and a sedentary lifestyle shall bolster the proliferation of the market. As per the data provided by the Oxford University Press, the number of patients in the European region have risen to over 1.5 million and over 4 million in the Asia Pacific region, with such a prevalence of spondylitis, the market is predicted to lead the market during the forecasted timeframe. 

Ankylosing Spondylitis Market Segmentation:

By Drug
•    Cosentyx
•    Humira
•    Simponi
•    Remicade
•    Embrel
•    Cimzia
By End User 
•    Hospitals
•    Clinics
•    Others
By Region
•    North America
•    Europe 
•    Asia Pacific
•    Latin America
•    Middle East & Africa

The market is categorized into drug, end user and region. The drug segment is fragmented into Cosentyx, Humira, Simponi, Enbrel and Cimzia. The Humira drug is estimated to hold the largest ankylosing spondylitis market share and this is credited to its high efficacy and low cost. The Cosentyx, however, it predicted to grow at a substantial rate during the forecasted timeframe owing to the expiration of patents in the European region. The end user segment is classified into hospitals, clinics and others. 

Regional Analysis:
The North America region is expected to dominate the global market, and this can be attributed to the prevalence of spondylitis owing to the rising geriatric population, increased sedentary lifestyle and a lack of exercise. Furthermore, a strong presence of key market players along with increased investments for research and development for advanced spondylitis products shall boost the market growth in the region.

Competitive Landscape:                            
The prominent players of the market are AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen Inc., Protalix BioTherapeutics, Inc., Reliance Life Sciences Pvt. Ltd., Momenta Pharmaceuticals Inc., Celgene Corporation, Regeneron Pharmaceuticals, and Merck & Co. Inc.  

FutureWise Key Takeaways:
•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:
•    To provide with an exhaustive analysis on the global ankylosing spondylitis market by drug, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

Flexible Delivery Model:
•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics